Skip to content
MPLTMapLight Therapeutics, Inc.

Earnings

When MapLight Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.

11 quarters. Mar 31, 2024 to Sep 30, 2026. mixed units.

Quarter by quarter

Q3 2026-$51.62MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 16, 2026, before the openThe release
    Revenue
    —
    —
    Net income
    -$51.62M
    N/M
    EPS
    -$0.97
    N/M
    On November 16, 2026, MapLight Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the third quarter ended September 30, 2026.
  2. Q2 2026Aug 13, 2026, after the closeThe release+1.3%by the close of Aug 14
    Revenue
    —
    —
    Net income
    -$60.19M
    N/M
    EPS
    -$1.32
    N/M
  3. Q1 2026May 14, 2026, after the closeThe release1.9%by the close of May 15
    Revenue
    —
    —
    Net income
    -$60.67M
    N/M
    EPS
    -$1.34
    N/M
  4. Q4 2025Mar 26, 2026, before the openThe release+6.0%by the close of Mar 26
    Revenue
    —
    —
    Net income
    -$79.55M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 16, 2026 · pre-marketNov 16, 202647 d10-Q——-$0.97—
Q2 2026Jun 30, 2026Aug 13, 2026 · after-hoursAug 13, 202644 d10-Q——-$1.32+1.3%
Q1 2026Mar 31, 2026May 14, 2026 · after-hoursMay 14, 202644 d10-Q——-$1.341.9%
FY 2025
Q4 2025derivedDec 31, 2025Mar 26, 2026 · pre-marketMar 26, 202685 d10-K———+6.0%
Q3 2025Sep 30, 2025Dec 4, 2025 · pre-marketDec 4, 202565 d10-Q——-$37.18+8.2%
Q2 2025Jun 30, 2025——————-$39.11—
Q1 2025Mar 31, 2025——————-$29.33—
FY 2024
Q4 2024derivedDec 31, 2024————————
Q3 2024Sep 30, 2024——————-$25.08—
Q2 2024Jun 30, 2024————————
Q1 2024Mar 31, 2024————————

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 16, 2026462097
10-QAug 13, 2026349554
10-QMay 14, 2026224129
10-KMar 26, 2026125072
10-QDec 4, 2025307453

Provenance

ProvenanceData status and checks

MapLight Therapeutics, Inc. · CIK 1770069 · Engraved from SEC EDGAR